Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease
Crossref DOI link: https://doi.org/10.1007/s11914-017-0403-y
Published Online: 2017-09-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McDonald, Michelle M.
Delgado-Calle, Jesus
License valid from 2017-09-27